We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Researchers Reveal a Microchip Magnetic Cell Sorting Device

By LabMedica International staff writers
Posted on 07 Mar 2016
Print article
Image: Progressively spaced micropillars highlight the new magnetic ratcheting cell sorting system (Photo courtesy of University of California, Los Angeles).
Image: Progressively spaced micropillars highlight the new magnetic ratcheting cell sorting system (Photo courtesy of University of California, Los Angeles).
A novel magnetic cell sorting system may potentially be reduced in size for development into a "lab-on-a-chip" device.

The system, which was invented by investigators at the University of California, Los Angeles (USA), comprised a microchip coated with an array of microscale pillars set progressively farther apart, and a spinning magnet that pulled magnetically labeled cells over the pillars. The system separated and concentrated magnetic beads based on iron oxide content (IOC) and cells based on surface expression. Particles with higher IOC separated and equilibrated along the miropillar array at larger pitches.

The investigators described using the method in the February 17, 2016, online edition of the journal Small. They reported that LNCaP cells were separated based on the bound quantity of one-micrometer anti-epithelial cell adhesion molecule (EpCAM) particles as a metric for expression. The ratcheting cytometry system was able to resolve a differential of 13 bound particles, successfully distinguishing LNCaP from PC3 populations based on EpCAM expression. This result matched that obtained with fluorescence-based flow cytometry analysis. As a proof-of-concept, EpCAM-labeled cells from patient blood were isolated with 74% purity, demonstrating the device's potential as a quantitative magnetic separation instrument.

“What we think is only one cell type is often a heterogeneous mixture, and without technologies to separate quantitatively, these nuanced differences get lost,” said senior author Dr. Dino Di Carlo, professor of bioengineering at the University of California, Los Angeles. “For example, therapeutically active progenitor cells may look very similar to the other contaminating cells that provide no therapeutic benefit.”

Related Links:

University of California, Los Angeles


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.